Project Grant HT94252510718
Award Date 10/1/25
Completion Date 9/30/28
Dollars Obligated $695K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Chapel Hill, NC 27599, USA
Similar Awards
- The Defense Health Agency awarded a $784,602 Project Grant to Dana-Farber Cancer Institute, Inc. (doing business as Dfci) under the Military Medical Research and Development program (CFDA 12.420). The grant will support research from January 2023 to January 2026 to develop next-generation immunotherapy for breast cancer by turning breast cancer cells against themselves. The Military Medical Research and Development program aims to transform military and public health through innovative medical...
- This federal Project Grant award of $724,500.00 from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), is supporting research conducted by Duke University in Durham, North Carolina. The funding will target dormancy-associated immune tolerance to eliminate residual breast cancer, with the award period running from March 1, 2025 to February 29, 2028. The Defense Health Agency is the primary funding agency for this program, which supports advanced...
- This federal Project Grant award, titled "The Breast Cancer Cellular Atlas", was awarded on March 1, 2025 by the Defense Health Agency, a defense agency under the U.S. Department of Defense, under the Military Medical Research and Development (CFDA 12.420) program. The $1,541,280.00 award will support advanced biomedical research at the University of North Carolina at Chapel Hill (UNC-CH) over a performance period ending on February 28, 2029. The research aims to transform healthcare...
- The Defense Health Agency awarded Duke University a $3,811,150.00 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct a research project titled "SINGLE-CELL AND SPATIAL ANALYSIS OF LETHAL BREAST CANCERS". The grant period runs from April 1, 2024 to March 31, 2028. The key products and services to be delivered under this award include comprehensive single-cell and spatial analysis of breast cancer samples to characterize tumor heterogeneity...
- This Defense Health Agency Project Grant award of $1,204,899 to Duke University, with a period of performance from January 1, 2024 to December 31, 2027, supports targeted vaccination research to treat and prevent endocrine-resistant ER+ breast cancer. The project aims to develop new treatments by targeting common resistance genes and neoepitope mutations. This grant is funded through the Department of Defense's Military Medical Research and Development program (CFDA 12.420), which supports...
- The Department of Defense's Defense Health Agency awarded a $4,818,759 Project Grant to Duke University under the Military Medical Research and Development program (CFDA 12.420) for the project "SINGLE-CELL AND SPATIAL ANALYSIS OF LETHAL BREAST CANCERS". The grant, awarded on April 1, 2024, will fund research to improve understanding and treatment of lethal breast cancers through advanced single-cell and spatial analysis techniques. This work supports the program's goals of...
- The federal Project Grant award titled "BREAST CANCER BRAIN METASTASES: INTEGRATING IMMUNOGENOMIC AND PHENOTYPIC VULNERABILITIES TO IMPROVE OUTCOMES" was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The $161,000 award to Duke University, a leading private research institution, will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The...
- This federal Project Grant award in the amount of $4,503,963 was made by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award supports a research project titled "Spatial Reprogramming of Tumor Immune Microenvironments by Preoperative Radiotherapy and Immune Checkpoint Inhibition in HER2 Negative Breast Cancer." The project is being led by the University of North Carolina at Chapel Hill (UNC-CH) through its Office of Sponsored...
- The Defense Health Agency awarded Duke University a $402,500 Project Grant under the Military Medical Research and Development program (CFDA 12.420) for the period of June 1, 2023 through May 31, 2025. The grant will support Duke University's research efforts to target the ferropotosis protection mechanism of serum to disable cancer metastasis. The Military Medical Research and Development program aims to transform military and public health through innovative medical research solutions for both...
- This Project Grant award in the amount of $6,965,603.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the development of a multiantigen vaccine (STEMVAC) for adjuvant treatment of patients with moderate or extensive residual triple-negative breast cancer. The award will fund research at the University of Washington from June 2025 through June 2029 to advance this innovative cancer treatment approach. The Military Medical...